Search

Search Constraints

You searched for: Author/Creator Staebler, Annette

Search Results

1. 2022-RA-1048-ESGO Circulating HPV cell-free DNA in cervical cancer. (20th October 2022)

2. 2022-RA-1492-ESGO Homologous recombination deficiency (HRD): a new ovarian cancer biomarker – validation of decentralized genomic profiling, with a focus on genomic large rearrangements (LRs). (20th October 2022)

3. 2022-RA-995-ESGO Independent prognostic significance of substantial lymphovascular space invasion (LVSI) in a consecutive series of primary LVSI-positive endometrial carcinoma (EC). (20th October 2022)

4. 21/#810 A current perspective on endometrial carcinoma (EC) risk classification: results from an European multicentre initiative. (4th December 2022)

5. Adult‐type granulosa cell tumor of the ovary: a FOXL2‐centric disease. (11th January 2021)

6. Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. (21st September 2018)

7. CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. Issue 5 (26th December 2022)

8. CD56 (Neural Cell Adhesion Molecule) Expression in Ovarian Carcinomas: Association With High-Grade and Advanced Stage But Not With Neuroendocrine Differentiation. Issue 2 (1st February 2017)

9. CD56 (Neural Cell Adhesion Molecule) Expression in Ovarian Carcinomas: Association With High-Grade and Advanced Stage But Not With Neuroendocrine Differentiation. Issue 2 (February 2017)

10. Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer. Issue 4 (1st May 2016)